The PD-L1/4-1BB Bispecific Antibody-Anticalin Fusion Protein PRS-344/S095012 Elicits Strong T-Cell Stimulation in a Tumor-Localized Manner.
Peper-Gabriel JK, Pavlidou M, Pattarini L, Morales-Kastresana A, Jaquin TJ, Gallou C, Hansbauer EM, Richter M, Lelievre H, Scholer-Dahirel A, Bossenmaier B, Sancerne C, Riviere M, Grandclaudon M, Zettl M, Bel Aiba RS, Rothe C, Blanc V, Olwill SA.
Peper-Gabriel JK, et al. Among authors: lelievre h.
Clin Cancer Res. 2022 Aug 2;28(15):3387-3399. doi: 10.1158/1078-0432.CCR-21-2762.
Clin Cancer Res. 2022.
PMID: 35121624
Free PMC article.